Oracle Investment Management as of Sept. 30, 2014
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 27 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 16.1 | $117M | 5.4M | 21.48 | |
| Quidel Corporation | 10.8 | $78M | 2.9M | 26.87 | |
| Tenet Healthcare Corporation | 10.7 | $78M | 1.3M | 59.39 | |
| Acorda Therapeutics | 8.7 | $63M | 1.9M | 33.88 | |
| NxStage Medical | 6.8 | $49M | 3.8M | 13.13 | |
| Opko Health (OPK) | 6.8 | $49M | 5.7M | 8.51 | |
| Mazor Robotics Ltd. equities | 5.1 | $37M | 3.2M | 11.78 | |
| Transition Therapeutics | 4.6 | $34M | 4.9M | 6.90 | |
| Thoratec Corporation | 4.5 | $33M | 1.2M | 26.73 | |
| Hansen Medical | 4.2 | $31M | 26M | 1.18 | |
| Accuray Incorporated (ARAY) | 3.7 | $27M | 3.6M | 7.26 | |
| Biolase Technology | 2.9 | $21M | 8.4M | 2.49 | |
| Chimerix (CMRX) | 2.3 | $17M | 600k | 27.62 | |
| Pacific Biosciences of California (PACB) | 2.2 | $16M | 3.2M | 4.91 | |
| Tesaro | 2.1 | $15M | 556k | 26.92 | |
| Vermillion | 1.8 | $13M | 7.1M | 1.79 | |
| WebMD Health | 1.5 | $11M | 252k | 41.81 | |
| Repros Therapeutics | 1.4 | $10M | 1.0M | 9.90 | |
| Intrexon | 0.9 | $6.8M | 369k | 18.58 | |
| Amarin Corporation (AMRN) | 0.8 | $5.9M | 5.4M | 1.09 | |
| Metabolix | 0.7 | $4.8M | 5.2M | 0.91 | |
| shares Agenus | 0.5 | $3.6M | 1.2M | 3.11 | |
| Derma Sciences | 0.4 | $2.7M | 327k | 8.33 | |
| Biogen Idec (BIIB) | 0.3 | $2.6M | 7.7k | 330.83 | |
| Ladenburg Thalmann Financial Services | 0.1 | $474k | 112k | 4.24 | |
| Celldex Therapeutics | 0.0 | $324k | 25k | 12.96 | |
| GTx | 0.0 | $196k | 265k | 0.74 |
